Osiris Therapeutics researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its product Grafix is a cryopreserved placental membrane for treating hard-to-treat acute and chronic wounds, venous leg ulcers, and burns. In addition, the Company offers BIO4, a bone allograft for use in all surgical applications, including spine, trauma, extremity, cranial, and foot and ankle surgery, and Cartiform, a viable chondral allograft that promotes articular cartilage repair to treat focal chondral defects.
Gross profit (FY, 2018)
Gross profit margin (FY, 2018), %
Net income (FY, 2018)
Market capitalization (16-Apr-2019)
Closing stock price (16-Apr-2019)
When was Osiris Therapeutics founded?
Osiris Therapeutics was founded in 1992.
Who are Osiris Therapeutics key executives?
Osiris Therapeutics's key executives are Linda Chang and Jason Keefer.
How many employees does Osiris Therapeutics have?
Osiris Therapeutics has 342 employees.
What is Osiris Therapeutics revenue?
Latest Osiris Therapeutics annual revenue is $142.8 m.
What is Osiris Therapeutics revenue per employee?
Latest Osiris Therapeutics revenue per employee is $417.6 k.
Who are Osiris Therapeutics competitors?
Competitors of Osiris Therapeutics include GenSight Biologics, Immusoft and Reneuron Group.
Where is Osiris Therapeutics headquarters?
Osiris Therapeutics headquarters is located at 7015 Albert Einstein Dr, Columbia.
Where are Osiris Therapeutics offices?
Osiris Therapeutics has an office in Columbia.
How many offices does Osiris Therapeutics have?
Osiris Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies